Fig. 3From: Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factorsNetwork analysis of the treatment patterns. Lines on the top of the nodes depict switches from left to right and lines below the nodes depict switches from right to left. FTY: fingolimod; NTZ: natalizumab; IFN: interferons; GA: glatiramer acetate; SUS: suspension; TRF: teriflunomide; DMF: dimethylfumarate; RTX: rituximab; ALZ: alemtuzumab: OCR: ocrelizumabBack to article page